1
|
Deshmukh R, Harwansh RK, Garg A, Mishra S, Agrawal R, Jangde R. COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2. Curr Genomics 2024; 25:69-87. [PMID: 38751601 PMCID: PMC11092912 DOI: 10.2174/0113892029291098240129113500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Revised: 01/11/2024] [Accepted: 01/17/2024] [Indexed: 05/18/2024] Open
Abstract
SARS-CoV-2 is a highly contagious and transmissible viral infection that first emerged in 2019 and since then has sparked an epidemic of severe respiratory problems identified as "coronavirus disease 2019" (COVID-19) that causes a hazard to human life and safety. The virus developed mainly from bats. The current epidemic has presented a significant warning to life across the world by showing mutation. There are different tests available for testing Coronavirus, and RT-PCR is the best, giving more accurate results, but it is also time-consuming. There are different options available for treating n-CoV-19, which include medications such as Remdesivir, corticosteroids, plasma therapy, Dexamethasone therapy, etc. The development of vaccines such as BNT126b2, ChAdOX1, mRNA-1273 and BBIBP-CorV has provided great relief in dealing with the virus as they decreased the mortality rate. BNT126b2 and ChAdOX1 are two n-CoV vaccines found to be most effective in controlling the spread of infection. In the future, nanotechnology-based vaccines and immune engineering techniques can be helpful for further research on Coronavirus and treatment of this deadly virus. The existing knowledge about the existence of SARS-CoV-2, along with its variants, is summarized in this review. This review, based on recently published findings, presents the core genetics of COVID-19, including heritable characteristics, pathogenesis, immunological biomarkers, treatment options and clinical updates on the virus, along with patents.
Collapse
Affiliation(s)
- Rohitas Deshmukh
- Department of Pharmaceutics, Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India
| | - Ranjit Kumar Harwansh
- Department of Pharmaceutics, Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India
| | - Akash Garg
- Department of Pharmaceutics, Rajiv Academy for Pharmacy, NH-2, Mathura, Delhi Road, Chhatikara, 281001, Uttar Pradesh, India
| | - Sakshi Mishra
- Department of Pharmaceutics, Institute of Pharmaceutical Research, GLA University, Mathura, 281406, Uttar Pradesh, India
| | - Rutvi Agrawal
- Department of Pharmaceutics, Rajiv Academy for Pharmacy, NH-2, Mathura, Delhi Road, Chhatikara, 281001, Uttar Pradesh, India
| | - Rajendra Jangde
- Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, 492010, India
| |
Collapse
|
2
|
Combaluzier S, Loosveld M, Nivaggioni V. Detection of unstable haemoglobin variants with Sysmex XN-10. Int J Lab Hematol 2023; 45:e21-e23. [PMID: 36113870 DOI: 10.1111/ijlh.13967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 08/29/2022] [Indexed: 11/30/2022]
Affiliation(s)
- Sophie Combaluzier
- Laboratoire d'Hématologie, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France
| | - Marie Loosveld
- Laboratoire d'Hématologie, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France.,CNRS, INSERM, CIML, Aix Marseille University, Marseille, France
| | - Vanessa Nivaggioni
- Laboratoire d'Hématologie, Hôpital de la Timone, Assistance Publique-Hôpitaux de Marseille, Marseille, France
| |
Collapse
|
3
|
Hoffmann JJML, Urrechaga E. Recent advances in laboratory hematology reflected by a decade of CCLM publications. Clin Chem Lab Med 2022; 61:829-840. [PMID: 36285728 DOI: 10.1515/cclm-2022-0962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2022] [Accepted: 09/27/2022] [Indexed: 11/15/2022]
Abstract
Abstract
On the occasion of the 60th anniversary of Clinical Chemistry and Laboratory Medicine (CCLM) we present a review of recent developments in the discipline of laboratory hematology as these are reflected by papers published in CCLM in the period 2012–2022. Since data on CCLM publications from 1963 to 2012 are also available, we were able to make a comparison between the two periods. This interestingly revealed that the share of laboratory hematology papers has steadily increased and reached now 16% of all papers published in CCLM. It also became evident that blood coagulation and fibrinolysis, erythrocytes, platelets and instrument and method evaluation constituted the ‘hottest’ topics with regard to number of publications. Some traditional, characteristic CCLM categories like reference intervals, standardization and harmonization, were more stable and probably will remain so in the future. With the advent of important newer topics, like new coagulation assays and drugs and cell population data generated by hematology analyzers, laboratory hematology is anticipated to remain a significant discipline in CCLM publications.
Collapse
Affiliation(s)
| | - Eloísa Urrechaga
- Biocruces Bizkaia Health Research Institute , Baracaldo , Spain
- Core Laboratory, Hospital Galdakao Usansolo , Vizcaya , Spain
| |
Collapse
|
4
|
Adam AS, Benyaich S, Colard M, Benghiat FS, Cotton F, Gulbis B. Rare unstable and low oxygen affinity haemoglobin variant, Hb Hazebrouck, detected on Sysmex XN-9000. Clin Chem Lab Med 2022; 60:e116-e118. [PMID: 35075886 DOI: 10.1515/cclm-2021-1301] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 01/17/2022] [Indexed: 11/15/2022]
Affiliation(s)
- Anne-Sophie Adam
- Department of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
| | - Sara Benyaich
- Department of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
| | - Martin Colard
- Department of Hematology, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Fleur Samantha Benghiat
- Department of Hematology, CUB-Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium
| | - Frédéric Cotton
- Department of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
| | - Béatrice Gulbis
- Department of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
| |
Collapse
|
5
|
Urrechaga E, Fernández M, Orbe RD. Hb Johnstown is detected on Mindray BC 6800 Plus analyzer. Clin Chem Lab Med 2021; 59:e386-e388. [PMID: 34087966 DOI: 10.1515/cclm-2021-0314] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Accepted: 05/10/2021] [Indexed: 11/15/2022]
Affiliation(s)
- Eloísa Urrechaga
- Biocruces Bizkaia Health Research Institute, Barakaldo, Vizcaya, Spain
| | | | - Rafael Del Orbe
- Erythropatology and Hematology, Hospital Universitario Cruces, Biscay, Spain
| |
Collapse
|
6
|
Debus J, Dumont B, Kouadio BN, Zucman N, Dumont LM, Peynaud-Debayle E. A case of methaemoglobinaemia interference on the WDF channel on Sysmex XN-Series analysers. Clin Chem Lab Med 2021; 59:e285-e287. [PMID: 34142514 DOI: 10.1515/cclm-2020-1704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/12/2020] [Accepted: 01/11/2021] [Indexed: 11/15/2022]
Affiliation(s)
- Jérôme Debus
- Service d'Hématologie Biologique et Transfusion, Hôpital Louis-Mourier,Colombes, France
| | - Bénédicte Dumont
- Service d'Hématologie Biologique et Transfusion, Hôpital Louis-Mourier,Colombes, France
| | - Blaise Naomi Kouadio
- Service d'Hématologie Biologique et Transfusion, Hôpital Louis-Mourier,Colombes, France
| | - Noémie Zucman
- Service de Réanimation Médicale, Hôpital Louis-Mourier, Colombes, France.,Université de Paris, IAME, INSERM UMR 1137, Paris, France
| | - Louis-Marie Dumont
- Service de Réanimation Médicale, Hôpital Louis-Mourier, Colombes, France
| | - Edith Peynaud-Debayle
- Service d'Hématologie Biologique et Transfusion, Hôpital Louis-Mourier,Colombes, France
| |
Collapse
|
7
|
Affiliation(s)
- David C. Klonoff
- Diabetes Research Institute,
Mills-Peninsula Medical Center, San Mateo, CA, USA
- David C. Klonoff, MD, FACP, FRCP (Edin),
Fellow AIMBE, Diabetes Research Institute, Mills-Peninsula Medical Center, 100 S
San Mateo Dr, Rm 5147, San Mateo, CA 94401, USA.
| |
Collapse
|
8
|
Jongbloed W, van Twillert G, Schoorl M, Schindhelm RK. Unstable haemoglobin variant Hb Leiden is detected on Sysmex XN-Series analysers. ACTA ACUST UNITED AC 2018; 56:e249-e250. [DOI: 10.1515/cclm-2017-1171] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 03/06/2018] [Indexed: 11/15/2022]
Affiliation(s)
- Wesley Jongbloed
- Department of Clinical Chemistry, Hematology and Immunology , Northwest Clinics , Alkmaar , The Netherlands
| | - Gitte van Twillert
- Department of Internal Medicine , Northwest Clinics , Alkmaar , The Netherlands
| | - Margreet Schoorl
- Department of Clinical Chemistry, Hematology and Immunology , Northwest Clinics , Alkmaar , The Netherlands
| | - Roger K. Schindhelm
- Department of Clinical Chemistry, Hematology and Immunology , Northwest Clinics , Alkmaar , The Netherlands
| |
Collapse
|